Dmg Group, LLC Liquidia Corp Transaction History
Dmg Group, LLC
- $126 Million
- Q2 2025
A detailed history of Dmg Group, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Dmg Group, LLC holds 15,719 shares of LQDA stock, worth $378,827. This represents 0.16% of its overall portfolio holdings.
Number of Shares
15,719
Previous 16,881
6.88%
Holding current value
$378,827
Previous $248,000
21.37%
% of portfolio
0.16%
Previous 0.21%
Shares
5 transactions
Others Institutions Holding LQDA
# of Institutions
201Shares Held
47.1MCall Options Held
475KPut Options Held
527K-
Black Rock Inc. New York, NY4.24MShares$102 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$102 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$86.6 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.89MShares$69.6 Million20.5% of portfolio
-
Opaleye Management Inc. Boston, MA2.26MShares$54.5 Million9.17% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.55B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...